The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Filter
To Preprint or Not to Preprint: Debate at the 17th Annual ISMPP Meeting
The Covid-19 pandemic has brought with it a deluge of preprints. While timely sharing of...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
Artificial Intelligence Is Democratizing Research and There’s More to Come
Today AI technologies are employed to both create and consume research. Scientists across the world...
Knowledge Exchange in a New Virtual World: How the Pandemic Redefined MSL-HCP Interactions
The pandemic threw a curve ball at MSL-HCP relationships, which have traditionally relied on face-to-face...
Counting on AI: The Right Time for Researchers and Pharma to Embrace Artificial Intelligence
The right AI–powered tools and techniques can make a significant difference in how research is...
EU MedTech Summit 2020: Highlights and Top 3 Takeaways
How is the MedTech industry gearing up for the EU-MDR? Here are some key takeaways...